Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Acromegaly 2Pituitary Neoplasms 1Hyperplasia 1Fibrous Dysplasia, Polyostotic 1Brain Neoplasms 1Adenoma 1

Interventions

pasireotide 4Cabergoline 3Surgical Procedures, Operative 2Propofol 2Octreotide 2Human Growth Hormone 2pegvisomant 1entinostat 1corticorelin ovine 1Yoga 1Thyrotropin-Releasing Hormone 1Surveys and Questionnaires 1Supine Position 1Sevoflurane 1Resistance Training 1Radiotherapy 1Radiosurgery 1Photochemotherapy 1Nivolumab 1Neurosurgical Procedures 1Lapatinib 1Ipilimumab 1Ibuprofen 1Hydrocortisone 1Growth Hormone 1Dosage Forms 1Dihematoporphyrin Ether 1Dexamethasone 1Desflurane 1Continuous Glucose Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pituitary Neoplasms × pegvisomant × Clear all
NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡